Investor Diligence and Decision Support
We support VC/CVC teams, Private Equity, Hedge Funds, and other investors with decision-grade intelligence in BioPharma, HealthTech, and AI-enabled healthcare. From fast diligence to ongoing monitoring, we help you validate assumptions, surface risks early, and act with confidence.
From identifying emerging trends and hidden risks to supporting diligence and portfolio decisions, we deliver concise, actionable recommendations that create an edge.
Our work commonly includes:
- Landscape + diligence (science, commercial, competitive dynamics)
- Company/asset profile (TAM, segmentation, growth drivers, value proposition)
- Opportunity/risk assessment (red flags, catalysts, scenarios, mitigations)
- Custom research aligned to your thesis and timelines (deal-specific questions, thesis validation, monitoring)
Typical engagement modes:
- Diligence Sprint (5–10 business days)
- Monthly monitoring and brief updates
- Decision workshops and AI-powered wargaming when stakes are high
Don’t forget to check out our Lucid Diligence Briefs, delivering 60-second theses, questions to ask, red flags and catalysts to watch, linked to trending news.
Want to move faster on your next decision? Contact: info@lqventures.com
March 11, 2025
Obesity Weekly News – March 11th 2025
March 11, 2025
Hematology Weekly News – March 11th 2025
March 10, 2025
Oncology Weekly Update – March 10th 2025
March 7, 2025
AAD 2025 Preview: Key Dermatology Highlights to Watch
March 4, 2025
Obesity Weekly News – March 4th 2025
March 3, 2025
Hematology Weekly News – March 3rd 2025
March 3, 2025
Oncology Weekly Update – March 3rd 2025
February 28, 2025
AAAAI 2025 Preview: Key Allergy, Asthma and Immunology Highlights to Watch
February 25, 2025
Obesity Weekly News – Feb 25th 2025
February 24, 2025
Hematology Weekly News – February 24th 2025
February 24, 2025